Literature DB >> 10968695

Transformation of hepatitis B virus-related membranous glomerulonephritis to crescentic form.

H Taskapan1, O Oymak, A Dogukan, O Ozbakir, C Utas.   

Abstract

We report a case of hepatitis B virus-(HBV) related membranous glomerulonephritis which progressed to crescentic transformation after withdrawal of immunosuppressive treatment. Immunosuppressive therapy probably enhanced HBV replication, and its withdrawal led to a return of immune competence resulting in progression of the glomerulonephritis. Prior screening of all patients for hepatitis B surface antigen, before using immunosuppressive therapy may prevent this complication. The usage of immunosuppressive therapy as a first-line choice in HBV-related glomerulonephritis may result in harmful complications.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968695

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  6 in total

Review 1.  Meta-analysis of combined therapy for adult hepatitis B virus-associated glomerulonephritis.

Authors:  Xiao-Yong Zheng; Ri-Bao Wei; Li Tang; Ping Li; Xiao-Dong Zheng
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

2.  Immune mediated crescentic MPGN secondary to HBV infection: A rare presentation for a common infection.

Authors:  Aswani Srinivas Mareddy; Dharshan Rangaswamy; Mahesha Vankalakunti; Ravindra Prabhu Attur; Shankar Prasad Nagaraju; Neeraja Koti
Journal:  Australas Med J       Date:  2016-01-31

3.  Treatment of hepatitis B virus-associated glomerulonephritis: a meta-analysis.

Authors:  Yu Zhang; Jian-Hua Zhou; Xiao-Ling Yin; Feng-Yu Wang
Journal:  World J Gastroenterol       Date:  2010-02-14       Impact factor: 5.742

Review 4.  Hepatic disorders in chronic kidney disease.

Authors:  Fabrizio Fabrizi; Piergiorgio Messa; Carlo Basile; Paul Martin
Journal:  Nat Rev Nephrol       Date:  2010-04-13       Impact factor: 28.314

5.  Combination therapy with lamivudine and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker for hepatitis B virus-associated glomerulonephritis with mild to moderate proteinuria: a clinical review of 38 cases.

Authors:  Li-Jing Sun; Jian-Ping Shan; Ruo-Lan Cui; Wei-Jie Yuan; Geng-Ru Jiang
Journal:  Int Urol Nephrol       Date:  2017-03-10       Impact factor: 2.370

Review 6.  Infection-Related Focal Segmental Glomerulosclerosis in Children.

Authors:  Anne Katrin Dettmar; Jun Oh
Journal:  Biomed Res Int       Date:  2016-05-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.